|
Real-time Estimate
Cboe BZX
15:55:51 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 2.385 USD | +2.80% |
|
-3.04% | -37.14% |
| 09-29 | Larimar Therapeutics Names John Harlow COO | MT |
| 09-28 | Larimar Therapeutics, Inc. Announces Appointment of John Harlow as President and Chief Operating Officer, Effective September 29, 2026 | CI |
Stock exchange
Quotes 5-day view: Larimar Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-11-02 | 2026-11-03 | 2026-11-04 | 2026-11-05 | 2026-11-06 | |
|---|---|---|---|---|---|
| Last | US$2.370 | US$2.540 | US$2.760 | US$2.320 | US$2.395 |
| Volume | 667,725 | 1,648,298 | 1,991,696 | 1,772,941 | 835,937 |
| Change | -4.05% | +7.17% | +8.66% | -15.94% | +2.80% |
| Opening | US$2.490 | US$2.390 | US$2.600 | US$2.760 | US$2.355 |
| High | US$2.566 | US$2.620 | US$2.780 | US$2.830 | US$2.475 |
| Low | US$2.340 | US$2.323 | US$2.570 | US$2.260 | US$2.300 |
Performance
| 1 day | +2.80% | ||
| 1 week | -3.04% | ||
| Current month | -3.04% | ||
| 1 month | -13.85% | ||
| 3 months | -42.98% | ||
| 6 months | -42.29% | ||
| Current year | -37.14% | ||
| 1 year | -30.98% | ||
| 3 years | -22.74% | ||
| 5 years | -81.55% |
Volumes
marketsDaily volume
835,937
Estimated daily volume
877,486
Avg. Volume 20 sessions
1,651,727
Daily volume ratio
0.53
Avg. Volume 20 sessions USD
3,939,368.9
Record volume 1
81,028,325
Record volume 2
70,424,355
Record volume 3
23,784,277
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
242,168,413
Net sales (USD)
0
Number of employees
71
Sales / Employee (USD)
0
Free-Float
97.46%
Free-Float capitalization (USD)
234,882,080
Average Daily Capital Traded
1.63%
Indicators
Moving average 5 days
2.492
Moving average 20 days
2.385
Moving average 50 days
3.12
Moving average 100 days
3.468
Price spread / (MMA5)
+4.49%
Price spread / (MMA20)
+0.01%
Price spread / (MMA50)
+30.80%
Price spread / (MMA100)
+45.43%
STIM
RSI 9 days
60.27
RSI 14 days
53.09
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.80% | -3.04% | -30.98% | -22.74% | 242M | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 57.24B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 57.62B | |
| +2.58% | +2.28% | +29.67% | +37.82% | 43.65B | |
| +4.91% | +10.45% | +23.07% | +108.54% | 44.03B | |
| +8.45% | +1.75% | +217.14% | +803.71% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | +0.58% | +0.70% | +48.19% | +131.02% | 40.47B | |
| Weighted average by Cap. | +0.08% | +2.43% | +52.57% | +140.07% |
Historical Quotes: Larimar Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
27b2f1195ef8f7f04b0f17cc8cb663.XYMWDV3UbGQT2xuEbbypUzzCU_0an6glMIcvFWJDEMw.GbZcPx6VDg9hnWHjFOnoZkmRFZRF19FSb-Z3LQZxeIVwtG9HHr42XH22fA
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:41:07 | 2.395 | 200 | 774,348 |
| 15:41:07 | 2.395 | 200 | 774,148 |
| 15:41:07 | 2.395 | 100 | 773,948 |
| 15:41:07 | 2.395 | 400 | 773,848 |
| 15:41:07 | 2.395 | 200 | 773,448 |
| 15:41:07 | 2.395 | 200 | 773,248 |
| 15:41:07 | 2.395 | 200 | 773,048 |
| 15:41:07 | 2.395 | 200 | 772,848 |
| 15:40:13 | 2.400 | 314 | 772,648 |
| 15:40:13 | 2.400 | 293 | 772,334 |
Price Extremes
| 1 week | 2.26 |  | 2.83 |
| 1 month | 1.92 | | 2.84 |
| Current year | 1.92 | | 6.42 |
| 1 year | 1.92 | | 6.42 |
| 3 years | 1.61 | | 13.68 |
| 5 years | 1.53 | | 13.68 |
| 10 years | 1.53 | | 25.87 |
Monthly variations
Annual variations
| 2026 | -39.11% | ||
| 2025 | -1.55% | ||
| 2024 | -14.95% | ||
| 2023 | +10.17% | ||
| 2022 | -61.72% | ||
| 2021 | -49.60% | ||
| 2020 | +74.07% |
- Stock Market
- Stocks
- LRMR Stock
- Quotes Larimar Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
